Skip to content
Screener

Bio-Techne Corp. TECH Q2 2026 earnings

Reported February 4, 2026 · Before market open

Revenue$295.9MBeat by $5.4M
EPS$0.46Beat by $0.03
Revenue estimate$290.5M
EPS estimate$0.43

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$292.4M
EPS estimate$0.46

Financials

Q2 2026

Income statement

See full
Revenue$295.9M-0.4%
Gross profit$191.3M-1.3%
Operating income$54.5M+14.9%
Net income$38.0M+8.9%
EPS (diluted)$0.24+9.1%

Balance sheet

See full
Cash & equivalents$172.9M-2.6%
Total debt$350.9M-11.2%
Total equity$2.0B-3.2%
Total assets$2.5B-5.5%

Cash flow

See full
Operating cash flow$82.4M-2.3%
CapEx$5.9M-13.2%
Free cash flow$76.5M-1.3%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$9.16B-19.9%
Enterprise value$9.34B-19.9%
P/S7.5×-2.0×

Profitability

See full
Gross margin65.2%-0.4pp
FCF margin18.3%-2.9pp

Returns & leverage

See full
Debt / equity0.2×0.0×
Current ratio4.5×+0.6×

Segments

By product

See full
Consumables$235.4M+2.0%
Instruments$29.6M-4.1%
Service$22.3M-18.4%
Royalty$8.5M+5.1%

By segment

See full
Protein Sciences$215.1M+1.7%
Diagnostics And Spatial Biology$81.2M-3.5%

FAQ

When did Bio-Techne Corp. report Q2 2026 earnings?
Bio-Techne Corp. (TECH) reported Q2 2026 earnings on February 4, 2026 before market open.
What were Bio-Techne Corp.'s Q2 2026 revenue and EPS?
Bio-Techne Corp. reported revenue of $295.9M and eps of $0.46 for Q2 2026.
Did Bio-Techne Corp. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $290.5M by $5.4M. EPS beat the consensus estimate of $0.43 by $0.03.
How did Bio-Techne Corp.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.4% from $297.0M a year earlier and eps grew 9.5% from $0.42.
Where can I find Bio-Techne Corp.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-009994) and the 10-Q periodic report (0001104659-26-010335) directly on SEC EDGAR. The filing index links above go to sec.gov.